Tech Company Financing Transactions
Retia Medical Funding Round
Fresenius Medical Care, Pritzker Vlock Family Office and Red Cedar Ventures joined a $15 million Series B funding round for Retia Medical. The round was recorded on 7/18/2022.
Transaction Overview
Company Name
Announced On
7/18/2022
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors
Proceeds Purpose
The company will use the funding to expand its commercial team and accelerate the development of its next-generation algorithms for guiding care for high-risk patients.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
7 Dana Rd. 111
Valhalla, NY 10595
USA
Valhalla, NY 10595
USA
Phone
Website
Email Address
Overview
Retia Medical develops monitors for high-risk patients. Retia's first product monitors cardiac output, a critical health metric that indicates the flow rate of blood pumped by the heart. The initial target market for this technology is the ICU and operating rooms. It is potentially extendable for use in emergency rooms or at home.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Marc Zemel
Chief Technical Officer
Ramakrishna Mukkamala
Executive Vice President
Jerry Korten
VP - Engineering
Alexander Markovic
Browse more venture capital transactions:
Prev: 7/18/2022: Cornerstone AI venture capital transaction
Next: 7/18/2022: KitaBeli venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record funding rounds that are announced publicly. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs